BeiGene, Ltd. (BGNE)
USD 184.71
(0.49%)
USD 184.71
(0.49%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -881.7 Million USD | 56.0% |
| 2022 | -2 Billion USD | -41.78% |
| 2021 | -1.41 Billion USD | 11.69% |
| 2020 | -1.6 Billion USD | -68.37% |
| 2019 | -950.57 Million USD | -41.08% |
| 2018 | -673.76 Million USD | -623.67% |
| 2017 | -93.1 Million USD | 21.9% |
| 2016 | -119.21 Million USD | -108.78% |
| 2015 | -57.1 Million USD | -212.41% |
| 2014 | -18.27 Million USD | -143.9% |
| 2013 | -7.49 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -251.15 Million USD | 31.67% |
| 2024 Q2 | -120.4 Million USD | 52.06% |
| 2023 Q3 | 215.41 Million USD | 156.52% |
| 2023 Q4 | -367.55 Million USD | -270.63% |
| 2023 FY | -881.7 Million USD | 56.0% |
| 2023 Q1 | -348.43 Million USD | 21.76% |
| 2023 Q2 | -381.13 Million USD | -9.39% |
| 2022 FY | -2 Billion USD | -41.78% |
| 2022 Q2 | -571.44 Million USD | -31.59% |
| 2022 Q1 | -434.27 Million USD | 25.85% |
| 2022 Q4 | -445.33 Million USD | 20.13% |
| 2022 Q3 | -557.55 Million USD | 2.43% |
| 2021 Q3 | -413.85 Million USD | 13.84% |
| 2021 Q4 | -585.65 Million USD | -41.51% |
| 2021 FY | -1.41 Billion USD | 11.69% |
| 2021 Q1 | 66.49 Million USD | 114.07% |
| 2021 Q2 | -480.34 Million USD | -822.37% |
| 2020 Q3 | -425.22 Million USD | -26.86% |
| 2020 Q4 | -472.74 Million USD | -11.18% |
| 2020 FY | -1.6 Billion USD | -68.37% |
| 2020 Q2 | -335.2 Million USD | 7.84% |
| 2020 Q1 | -363.73 Million USD | 6.27% |
| 2019 FY | -950.57 Million USD | -41.08% |
| 2019 Q4 | -388.06 Million USD | -26.26% |
| 2019 Q1 | -167.64 Million USD | 37.51% |
| 2019 Q2 | -85.57 Million USD | 48.96% |
| 2019 Q3 | -307.35 Million USD | -259.19% |
| 2018 Q2 | -156.88 Million USD | -49.99% |
| 2018 Q1 | -104.59 Million USD | -5.31% |
| 2018 FY | -673.76 Million USD | -623.67% |
| 2018 Q4 | -268.25 Million USD | -86.25% |
| 2018 Q3 | -144.03 Million USD | 8.19% |
| 2017 FY | -93.1 Million USD | 21.9% |
| 2017 Q2 | -60.54 Million USD | -19.6% |
| 2017 Q3 | 117.38 Million USD | 293.88% |
| 2017 Q4 | -99.32 Million USD | -184.61% |
| 2017 Q1 | -50.62 Million USD | -34.64% |
| 2016 Q1 | -22 Million USD | 19.26% |
| 2016 Q4 | -37.59 Million USD | -5.93% |
| 2016 Q3 | -35.49 Million USD | -47.13% |
| 2016 Q2 | -24.12 Million USD | -9.65% |
| 2016 FY | -119.21 Million USD | -108.78% |
| 2015 FY | -57.1 Million USD | -212.41% |
| 2015 Q2 | -5.64 Million USD | 44.76% |
| 2015 Q1 | -10.21 Million USD | -172.25% |
| 2015 Q3 | -13.99 Million USD | -148.17% |
| 2015 Q4 | -27.25 Million USD | -94.66% |
| 2014 Q3 | -9.75 Million USD | -309.35% |
| 2014 Q4 | -3.75 Million USD | 61.56% |
| 2014 FY | -18.27 Million USD | -143.9% |
| 2014 Q1 | -2.38 Million USD | 0.0% |
| 2014 Q2 | -2.38 Million USD | 0.0% |
| 2013 FY | -7.49 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -51.92 Million USD | -1598.041% |
| Jaguar Health, Inc. | -41.3 Million USD | -2034.886% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -476.31% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -1520.132% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -100.278% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1790.586% |
| ContextLogic Inc. | -317 Million USD | -178.141% |
| MiMedx Group, Inc. | 67.43 Million USD | 1407.416% |
| MEI Pharma, Inc. | 17.77 Million USD | 5059.546% |
| AlloVir, Inc. | -190.41 Million USD | -363.038% |
| Novavax, Inc. | -545.06 Million USD | -61.763% |
| Aptorum Group Limited | -2.82 Million USD | -31114.803% |
| Ardelyx, Inc. | -66.06 Million USD | -1234.566% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -329.525% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -1623.464% |
| Vaxcyte, Inc. | -402.26 Million USD | -119.185% |
| Precigen, Inc. | -95.9 Million USD | -819.365% |
| Pharming Group N.V. | -10.54 Million USD | -8259.006% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -337.373% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -3492.503% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -3414.041% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -315.469% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -4654.144% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -3522.57% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -3522.57% |
| Bicycle Therapeutics plc | -180.66 Million USD | -388.037% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -241.971% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -3137.051% |
| Acelyrin, Inc. | -381.64 Million USD | -131.031% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -2261.296% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -2485.578% |
| Senti Biosciences, Inc. | -92.91 Million USD | -848.9% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -742.136% |
| AbCellera Biologics Inc. | -146.39 Million USD | -502.268% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -2409.129% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -392.428% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -13089.349% |
| Chimerix, Inc. | -82.09 Million USD | -974.009% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -2902.888% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -4245.316% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -1876.777% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -1626.875% |
| Elevation Oncology, Inc. | -45.7 Million USD | -1829.17% |
| Alkermes plc | 355.75 Million USD | 347.84% |
| Fortress Biotech, Inc. | -60.63 Million USD | -1354.076% |
| Fortress Biotech, Inc. | -60.63 Million USD | -1354.076% |
| Agenus Inc. | -245.76 Million USD | -258.766% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -980.789% |
| Dyadic International, Inc. | -6.79 Million USD | -12874.955% |
| ImmuCell Corporation | -5.77 Million USD | -15168.734% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -94099.573% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -680.542% |
| Lantern Pharma Inc. | -15.96 Million USD | -5423.955% |
| Immix Biopharma, Inc. | -15.42 Million USD | -5615.709% |
| Incyte Corporation | 597.59 Million USD | 247.542% |
| IO Biotech, Inc. | -86.08 Million USD | -924.253% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -1412.545% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -4533.525% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -1394.859% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -435.752% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -10271.815% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -1102.105% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -135.984% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | -53.918% |
| NextCure, Inc. | -62.72 Million USD | -1305.717% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -8729.441% |
| Onconetix, Inc. | -37.4 Million USD | -2256.897% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -2133.36% |
| Opthea Limited | -220.24 Million USD | -300.336% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1953.244% |
| PureTech Health plc | -65.69 Million USD | -1242.083% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -1094.888% |
| Seer, Inc. | -86.27 Million USD | -921.95% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -7029556.318% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -2614.2% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -6645.082% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -2998.932% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -1433.059% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -1316.285% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -565.475% |
| ChromaDex Corporation | -4.93 Million USD | -17755.569% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -24473.802% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -763.827% |
| CRISPR Therapeutics AG | -153.61 Million USD | -473.991% |
| Precision BioSciences, Inc. | -61.31 Million USD | -1337.903% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -447.89% |
| Innoviva, Inc. | 179.72 Million USD | 590.595% |
| Summit Therapeutics Inc. | -614.92 Million USD | -43.384% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -1216.08% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -1240.695% |
| ESSA Pharma Inc. | -26.58 Million USD | -3216.893% |
| GlycoMimetics, Inc. | -36.89 Million USD | -2289.49% |
| GT Biopharma, Inc. | -7.59 Million USD | -11506.002% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -265.307% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 1334.712% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -1695.008% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -8763.395% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -259.009% |
| Aptose Biosciences Inc. | -51.2 Million USD | -1621.851% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -796.975% |
| Soligenix, Inc. | -6.14 Million USD | -14258.358% |
| Century Therapeutics, Inc. | -136.67 Million USD | -545.122% |
| Kura Oncology, Inc. | -152.63 Million USD | -477.673% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -888.262% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -8266.939% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 156024.806% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -154857.469% |
| Autolus Therapeutics plc | -208.38 Million USD | -323.119% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -1126.332% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -1145.438% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -3969.171% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -291.435% |
| GRI Bio, Inc. | -13.03 Million USD | -6663.12% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -21225.224% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -610.573% |
| IGM Biosciences, Inc. | -246.41 Million USD | -257.813% |
| INmune Bio, Inc. | -30 Million USD | -2838.243% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -697.5% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1989.663% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -5423.912% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -5482.203% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -1377.269% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -771.537% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -219.314% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -270.634% |
| Verastem, Inc. | -87.36 Million USD | -909.2% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -1527.128% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -446.504% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -655.806% |
| Histogen Inc. | -10.62 Million USD | -8201.554% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -6071.506% |
| Surrozen, Inc. | -43.04 Million USD | -1948.483% |
| Organovo Holdings, Inc. | -14.67 Million USD | -5909.87% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -17232.474% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -1584.611% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -3390.116% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -3173.101% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -10450.424% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -483.584% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -1702.124% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -2866.217% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -8363.554% |
| Apollomics, Inc. | -172.6 Million USD | -410.836% |
| Amarin Corporation plc | -59.11 Million USD | -1391.589% |
| Mesoblast Limited | -87.95 Million USD | -902.442% |
| Turnstone Biologics Corp. | -55.2 Million USD | -1497.297% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -499.956% |
| Synaptogenix, Inc. | -6.03 Million USD | -14501.431% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -5339.956% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -1030.105% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -18301.633% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -10393.78% |
| Exelixis, Inc. | 207.76 Million USD | 524.378% |
| Better Therapeutics, Inc. | -39.76 Million USD | -2117.575% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -512.518% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | -66.792% |
| NLS Pharmaceutics AG | -12.17 Million USD | -7143.722% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -11211.649% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -2767.436% |
| Gritstone bio, Inc. | -138.49 Million USD | -536.658% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -1267.731% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -21942.976% |
| Avid Bioservices, Inc. | -140.75 Million USD | -526.422% |
| Insmed Incorporated | -749.56 Million USD | -17.629% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -5704.717% |
| MediWound Ltd. | -6.71 Million USD | -13028.469% |
| OmniAb, Inc. | -50.61 Million USD | -1641.852% |
| Alector, Inc. | -130.39 Million USD | -576.203% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -675.305% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -1600.596% |
| Zai Lab Limited | -334.62 Million USD | -163.495% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -172.144% |
| Aura Biosciences, Inc. | -76.4 Million USD | -1053.947% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -275.783% |
| Immunic, Inc. | -93.61 Million USD | -841.875% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -548.825% |
| Veracyte, Inc. | -74.4 Million USD | -1085.028% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -11387.229% |
| FibroGen, Inc. | -284.23 Million USD | -210.207% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -3261.192% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -12492.429% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -4581.794% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 312.546% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -3809.147% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1889.507% |
| TG Therapeutics, Inc. | 12.67 Million USD | 7057.923% |
| Galecto, Inc. | -38.34 Million USD | -2199.168% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -4573.529% |
| Fortrea Holdings Inc. | -3.4 Million USD | -25832.588% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -596.21% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -4964.086% |
| XBiotech Inc. | -24.55 Million USD | -3490.455% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -1267.731% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -1306.682% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -795.808% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -4014.939% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -1497.5% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | -45.343% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -1191.785% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -1548549.313% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -289.208% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -3859.615% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -301.305% |
| NexImmune, Inc. | -32.34 Million USD | -2626.0% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -16578.249% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -6177.336% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 122.301% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -3540.263% |
| Scopus BioPharma Inc. | -11.6 Million USD | -7494.497% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -654.9% |
| Ainos, Inc. | -13.77 Million USD | -6302.853% |
| Pluri Inc. | -20.88 Million USD | -4121.122% |
| Prothena Corporation plc | -147.02 Million USD | -499.687% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -674.304% |
| Celularity Inc. | -196.29 Million USD | -349.175% |
| Rallybio Corporation | -74.56 Million USD | -1082.485% |
| Cue Biopharma, Inc. | -50.73 Million USD | -1637.938% |
| MeiraGTx Holdings plc | -84.02 Million USD | -949.315% |
| Omeros Corporation | -117.81 Million USD | -648.396% |
| Humacyte, Inc. | -110.77 Million USD | -695.938% |
| Immunocore Holdings plc | -55.28 Million USD | -1494.784% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -4802.736% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -3745.048% |
| Blueprint Medicines Corporation | -506.98 Million USD | -73.912% |
| CalciMedica, Inc. | -34.35 Million USD | -2466.313% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -1202.856% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -523.534% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -431.825% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -211.277% |
| Pulmatrix, Inc. | -14.12 Million USD | -6143.949% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -2405.208% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -966.952% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -83.234% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -740.755% |
| Cytokinetics, Incorporated | -526.24 Million USD | -67.547% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -2344.775% |
| Nutriband Inc. | -5.48 Million USD | -15973.975% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -2081.366% |
| Vor Biopharma Inc. | -117.86 Million USD | -648.079% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 120.274% |
| Evogene Ltd. | -23.87 Million USD | -3592.399% |
| ProKidney Corp. | -35.46 Million USD | -2385.925% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -636.211% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -11138.549% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | -37.081% |
| CorMedix Inc. | -46.33 Million USD | -1802.725% |
| BioLineRx Ltd. | -60.61 Million USD | -1354.628% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -766.595% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -2047.051% |
| Atai Life Sciences N.V. | -40.22 Million USD | -2091.995% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -993.25% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -1067.5% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -201.757% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -3062.965% |
| MediciNova, Inc. | -8.57 Million USD | -10186.488% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -615.225% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -10425.552% |
| GeoVax Labs, Inc. | -25.96 Million USD | -3295.525% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -268.548% |
| Biomea Fusion, Inc. | -117.25 Million USD | -651.958% |
| PTC Therapeutics, Inc. | -626.6 Million USD | -40.712% |
| Mereo BioPharma Group plc | -29.46 Million USD | -2892.289% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -475.67% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -321.144% |
| Absci Corporation | -110.56 Million USD | -697.449% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -2824.405% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -774.389% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -273.705% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 6360.352% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -356.933% |
| Allakos Inc. | -185.7 Million USD | -374.8% |
| Imunon, Inc. | -19.51 Million USD | -4418.109% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -805.849% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 930.703% |
| BioAtla, Inc. | -123.46 Million USD | -614.153% |
| NLS Pharmaceutics AG | -12.17 Million USD | -7143.722% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -5383.941% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -169.417% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -2286.284% |
| XOMA Corporation | -40.83 Million USD | -2059.408% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -765.523% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -643.976% |
| aTyr Pharma, Inc. | -50.38 Million USD | -1649.803% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -905.609% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -480.992% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -270.88% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -2410.63% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -10796.126% |
| Akari Therapeutics, Plc | -10 Million USD | -8710.032% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -1309529.41% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 413.113% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -13129.128% |
| UroGen Pharma Ltd. | -102.24 Million USD | -762.357% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -725.623% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -11237.111% |
| Orgenesis Inc. | -55.36 Million USD | -1492.652% |
| Entera Bio Ltd. | -8.88 Million USD | -9819.091% |
| GH Research PLC | -35.58 Million USD | -2377.613% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -4130.845% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -1039.334% |
| Xencor, Inc. | -126.08 Million USD | -599.285% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -23314.174% |
| Replimune Group, Inc. | -215.79 Million USD | -308.588% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -4045.988% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 35241.809% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -13129.128% |
| Portage Biotech Inc. | -75.33 Million USD | -1070.321% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -10425.552% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -812.222% |
| OncoCyte Corporation | -27.78 Million USD | -3073.781% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -6471.47% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -7827.945% |
| Purple Biotech Ltd. | -19.88 Million USD | -4335.151% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -12461.732% |
| scPharmaceuticals Inc. | -54.81 Million USD | -1508.663% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -4936.564% |
| HilleVax, Inc. | -123.56 Million USD | -613.552% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -8623.736% |
| Tharimmune, Inc. | -9.31 Million USD | -9361.306% |
| Genprex, Inc. | -30.86 Million USD | -2757.08% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -273.724% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -2829.846% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -49378.563% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -16548.518% |
| OKYO Pharma Limited | -16.82 Thousand USD | -5240220.324% |
| Savara Inc. | -54.69 Million USD | -1511.957% |
| Curis, Inc. | -47.41 Million USD | -1759.633% |
| Daré Bioscience, Inc. | -30.16 Million USD | -2823.3% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -5608.663% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -15732.43% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -2857.263% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -4040.641% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -102.057% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -1016.722% |
| Erasca, Inc. | -125.04 Million USD | -605.129% |
| bluebird bio, Inc. | -211.91 Million USD | -316.071% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -17532.407% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 625.938% |
| DBV Technologies S.A. | -72.72 Million USD | -1112.37% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -17532.407% |
| Moderna, Inc. | -4.71 Billion USD | 81.296% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -2095.652% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -15384.861% |
| Molecular Templates, Inc. | -8.12 Million USD | -10753.127% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -1360.072% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -691.486% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -551.419% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -1739.997% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -523.428% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -358.244% |
| MacroGenics, Inc. | -9.05 Million USD | -9634.025% |
| RenovoRx, Inc. | -10.23 Million USD | -8517.162% |
| Adicet Bio, Inc. | -142.65 Million USD | -518.057% |
| Prime Medicine, Inc. | -198.13 Million USD | -345.008% |
| Aditxt, Inc. | -32.38 Million USD | -2622.931% |
| Adagene Inc. | -18.94 Million USD | -4553.704% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -11958.827% |
| Quantum-Si incorporated | -95.96 Million USD | -818.829% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -640.751% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -5948.306% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 766.295% |
| SciSparc Ltd. | -5.12 Million USD | -17114.135% |
| Vericel Corporation | -3.18 Million USD | -27609.239% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -733104.717% |
| Minerva Neurosciences, Inc. | -30 Million USD | -2838.502% |
| Generation Bio Co. | -126.61 Million USD | -596.386% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -1109.625% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -969.489% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -236.35% |
| Invivyd, Inc. | -198.64 Million USD | -343.866% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -157.83% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -10050.24% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 3966.123% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -8829.593% |
| 2seventy bio, Inc. | -217.57 Million USD | -305.253% |
| ADMA Biologics, Inc. | -28.23 Million USD | -3022.306% |
| Clene Inc. | -49.5 Million USD | -1681.084% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -3856.058% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -1683.606% |
| GeoVax Labs, Inc. | -25.96 Million USD | -3295.525% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -168.759% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -2609.37% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 3980.757% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -792.492% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -1079.479% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -448.309% |
| Vir Biotechnology, Inc. | -615.06 Million USD | -43.353% |
| Evaxion Biotech A/S | -22.12 Million USD | -3885.121% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -992.088% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -340.704% |
| Trevena, Inc. | -40.28 Million USD | -2088.458% |
| Surrozen, Inc. | -43.04 Million USD | -1948.483% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -1175.361% |
| Cingulate Inc. | -23.53 Million USD | -3646.378% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -12656.192% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -2112.012% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -11334.903% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -877.395% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -1338.678% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -1381.787% |
| Clearmind Medicine Inc. | -11.95 Million USD | -7275.205% |
| Kronos Bio, Inc. | -112.67 Million USD | -682.537% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -1174.2% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -34764412.682% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -926.495% |
| Statera Biopharma, Inc. | -174.4 Million USD | -405.543% |
| ImmunityBio, Inc. | -583.19 Million USD | -51.186% |
| Korro Bio, Inc. | -81.17 Million USD | -986.222% |
| Kineta, Inc. | -14.09 Million USD | -6153.692% |
| BioVie Inc. | -32.12 Million USD | -2644.998% |
| Codexis, Inc. | -76.24 Million USD | -1056.49% |
| Celularity Inc. | -196.29 Million USD | -349.175% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -310.997% |
| Celcuity Inc. | -63.77 Million USD | -1282.44% |
| Virax Biolabs Group Limited | -6.73 Million USD | -12994.277% |
| Cibus, Inc. | -267.62 Million USD | -229.454% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -2086.45% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -2362.115% |
| IN8bio, Inc. | -30 Million USD | -2838.341% |
| Kodiak Sciences Inc. | -260.49 Million USD | -238.479% |
| Annexon, Inc. | -134.23 Million USD | -556.829% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -652.535% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -1340.041% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -2695.169% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -140.716% |
| Eyenovia, Inc. | -27.26 Million USD | -3134.309% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 4183.683% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -164705.234% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -1054.008% |
| Arcellx, Inc. | -70.69 Million USD | -1147.288% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -2027.622% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -558.896% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -2835.406% |
| Moolec Science SA | -51.78 Million USD | -1602.504% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -1583.581% |
| Geron Corporation | -184.12 Million USD | -378.859% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -2000.605% |
| Royalty Pharma plc | 1.13 Billion USD | 177.695% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -548.525% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -9815.964% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -4050.536% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -413.606% |
| Humacyte, Inc. | -110.77 Million USD | -695.938% |
| Structure Therapeutics Inc. | -89.62 Million USD | -883.83% |
| 89bio, Inc. | -142.18 Million USD | -520.096% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -1178.579% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -8396.752% |
| Genelux Corporation | -28.29 Million USD | -3015.906% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -2933.573% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -397.805% |
| Notable Labs, Ltd. | -11.26 Million USD | -7727.663% |
| Liquidia Corporation | -78.5 Million USD | -1023.166% |
| Mustang Bio, Inc. | -51.6 Million USD | -1608.67% |
| Immunovant, Inc. | -259.33 Million USD | -239.987% |
| Quantum-Si incorporated | -95.96 Million USD | -818.829% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -1110.323% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -4449.342% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -818.542% |
| Acasti Pharma Inc. | -12.85 Million USD | -6759.939% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -3826.055% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -5423.912% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -383.411% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -20397.606% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -6970.634% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -2889.753% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -2161.486% |
| PepGen Inc. | -78.62 Million USD | -1021.395% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -2861.833% |
| United Therapeutics Corporation | 984.8 Million USD | 189.532% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -3860.952% |
| Solid Biosciences Inc. | -96.01 Million USD | -818.302% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -18301.633% |
| Immuneering Corporation | -53.47 Million USD | -1548.927% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -17232.474% |
| Silo Pharma, Inc. | -3.7 Million USD | -23725.548% |
| Belite Bio, Inc | -31.63 Million USD | -2687.393% |
| XOMA Corporation | -40.83 Million USD | -2059.408% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -1521.83% |
| Bionomics Limited | -15.49 Billion USD | 94.309% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -949.84% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -2924.001% |
| uniQure N.V. | -308.47 Million USD | -185.825% |
| Cassava Sciences, Inc. | -97.21 Million USD | -806.948% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -11958.827% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -614.338% |
| Forte Biosciences, Inc. | -31.47 Million USD | -2701.207% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -10650.304% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -2933.26% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -164705.234% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -3261.192% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -5248.547% |
| Altimmune, Inc. | -88.44 Million USD | -896.877% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -481.663% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -2924.001% |
| Compugen Ltd. | -18.75 Million USD | -4601.44% |
| Peak Bio, Inc. | -1259.26 USD | -70017847.048% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -1814.717% |
| Benitec Biopharma Inc. | -21.75 Million USD | -3953.644% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -160.252% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -962.888% |
| Zura Bio Limited | -60.36 Million USD | -1360.749% |
| PolyPid Ltd. | -23.86 Million USD | -3594.565% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -5504.551% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -962.888% |
| Instil Bio, Inc. | -156.08 Million USD | -464.882% |
| argenx SE | -295.05 Million USD | -198.83% |
| Immunome, Inc. | -106.8 Million USD | -725.523% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1974.9% |
| Verona Pharma plc | -54.36 Million USD | -1521.711% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -782.44% |
| Shattuck Labs, Inc. | -87.29 Million USD | -909.998% |
| CervoMed Inc. | -2.17 Million USD | -40496.665% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -607.341% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -6521.418% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1924.355% |
| Moolec Science SA | -51.78 Million USD | -1602.504% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -5098915.541% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -552.55% |
| AnaptysBio, Inc. | -163.61 Million USD | -438.879% |
| Design Therapeutics, Inc. | -66.86 Million USD | -1218.698% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -982.993% |
| NeurAxis, Inc. | -14.62 Million USD | -5928.079% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -2227.512% |
| Lumos Pharma, Inc. | -34.03 Million USD | -2490.668% |
| Achilles Therapeutics plc | -69.66 Million USD | -1165.64% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -782.44% |
| 180 Life Sciences Corp. | -19.93 Million USD | -4322.89% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 29404.405% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -34764412.682% |
| Nutriband Inc. | -5.48 Million USD | -15973.975% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -775.605% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -1713.953% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -1043.724% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -2495.549% |
| MoonLake Immunotherapeutics | -36 Million USD | -2348.695% |
| Palisade Bio, Inc. | -12.3 Million USD | -7068.358% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1993.125% |
| Beam Therapeutics Inc. | -132.52 Million USD | -565.304% |
| Neurogene Inc. | -36.31 Million USD | -2327.811% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -439.551% |
| AEON Biopharma, Inc. | -52.55 Million USD | -1577.654% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -798.355% |
| Sesen Bio, Inc. | -19.88 Million USD | -4334.259% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -1131.711% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -6945.831% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -98.566% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -690.302% |
| Athira Pharma, Inc. | -117.67 Million USD | -649.293% |
| Vaccinex, Inc. | -20.25 Million USD | -4253.899% |
| HCW Biologics Inc. | -24.99 Million USD | -3427.64% |
| XOMA Corporation | -40.83 Million USD | -2059.408% |
| Nektar Therapeutics | -276.05 Million USD | -219.395% |
| Arvinas, Inc. | -367.3 Million USD | -140.051% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -1309529.41% |
| Merus N.V. | -154.93 Million USD | -469.068% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -804.984% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -2709.329% |
| Rezolute, Inc. | -68.45 Million USD | -1187.936% |
| Clene Inc. | -49.5 Million USD | -1681.084% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -5616.664% |
| BeyondSpring Inc. | -21.02 Million USD | -4093.418% |
| Synlogic, Inc. | -57.28 Million USD | -1439.241% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -7308.688% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -8044.356% |
| Peak Bio, Inc. | -1259.26 USD | -70017847.048% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -2259.527% |
| Krystal Biotech, Inc. | 10.93 Million USD | 8165.386% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -516.152% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -171.208% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -18988.865% |
| MannKind Corporation | -11.93 Million USD | -7285.726% |
| Ikena Oncology, Inc. | -68.16 Million USD | -1193.472% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -4095.613% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -848.757% |
| Gossamer Bio, Inc. | -179.81 Million USD | -390.336% |
| CohBar, Inc. | -11.96 Million USD | -7270.835% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -3319.063% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -2824.405% |
| Legend Biotech Corporation | -518.25 Million USD | -70.13% |
| Mural Oncology plc | -207.44 Million USD | -325.028% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -610.396% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -4720.783% |
| Disc Medicine, Inc. | -76.42 Million USD | -1053.63% |
| Champions Oncology, Inc. | -7.27 Million USD | -12018.032% |
| REGENXBIO Inc. | -263.49 Million USD | -234.622% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -8207.753% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -1756.032% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -2221.292% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -780.273% |
| Vaxart, Inc. | -82.46 Million USD | -969.191% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 264271.882% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -2248.559% |
| Cellectis S.A. | -101.05 Million USD | -772.469% |
| Longeveron Inc. | -21.41 Million USD | -4017.629% |
| Repare Therapeutics Inc. | -93.79 Million USD | -840.027% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | -64.505% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -1138.893% |
| Revolution Medicines, Inc. | -436.36 Million USD | -102.057% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -13318.171% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -2760.459% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -1171.7% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -1262.09% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -8886.933% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 124.359% |
| Denali Therapeutics Inc. | -145.22 Million USD | -507.137% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -733104.717% |
| Veru Inc. | -93.15 Million USD | -846.519% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -3162.081% |
| Cingulate Inc. | -23.53 Million USD | -3646.378% |
| Passage Bio, Inc. | -102.06 Million USD | -763.894% |
| Context Therapeutics Inc. | -23.96 Million USD | -3579.27% |
| Exicure, Inc. | -16.91 Million USD | -5112.889% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -366.717% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -2234.784% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -13449.47% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -377.43% |
| Nuvalent, Inc. | -126.21 Million USD | -598.554% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -8284.717% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -914.869% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -2786.682% |
| OmniAb, Inc. | -50.61 Million USD | -1641.852% |
| Anew Medical, Inc. | 1.34 Million USD | 65599.712% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -5395.22% |
| Lipocine Inc. | -16.35 Million USD | -5292.023% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -1227.993% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -1284.7% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1989.663% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -1738.155% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -4346.11% |
| Sage Therapeutics, Inc. | -541.48 Million USD | -62.83% |
| Ocugen, Inc. | -63.07 Million USD | -1297.806% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -821.017% |
| Q32 Bio Inc. | -112.96 Million USD | -680.542% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -5028.595% |
| Alumis Inc. Common Stock | -154.99 Million USD | -468.87% |
| Equillium, Inc. | -13.33 Million USD | -6511.984% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -1360.604% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -10938.133% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -4577.192% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -1392.346% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -669.869% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -4697.64% |
| Dominari Holdings Inc. | -22.88 Million USD | -3753.282% |
| Edesa Biotech, Inc. | -8.37 Million USD | -10428.592% |
| vTv Therapeutics Inc. | -20.25 Million USD | -4254.114% |
| Bio-Techne Corporation | 168.1 Million USD | 624.498% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -150.423% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 784.274% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -623.708% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -2224.015% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -682.752% |
| Nkarta, Inc. | -117.5 Million USD | -650.383% |
| BioCardia, Inc. | -11.57 Million USD | -7519.981% |
| Iterum Therapeutics plc | -38.37 Million USD | -2197.85% |